Suchergebnisse - "Thummalapalli, Rohit"

PubPharm (29)

1

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma

enthalten in: bioRxiv.org | 2024

von Li, Z. | Zhuang, X. | Pan, C. | +14

2

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

enthalten in: Nature communications | 2024

von Middha, P. | Thummalapalli, R. | Betti, M. | +30

UpdateOf: medRxiv. 2023 Sep 13;:. - PMID 37292751

3

Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma

enthalten in: Cancer discovery | 2024

von Li, Z. | Zhuang, X. | Pan, C. | +14

UpdateOf: bioRxiv. 2023 Oct 01;:. - PMID 37808711

4

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC : A Multicenter Retrospective Cohort Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Nassar, A. | Kim, S. | Aredo, J. | +54

5

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2023

von Elkrief, A. | Riccuiti, B. | Alessi, J. | +18

ErratumIn: Oncologist. 2024 Jan 5;29(1):e166. - PMID 38000087

6

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Thummalapalli, R. | Ricciuti, B. | Bandlamudi, C. | +25

7

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma

enthalten in: bioRxiv : the preprint server for biology | 2023

von Li, Z. | Zhuang, X. | Pan, C. | +14

UpdateIn: Cancer Discov. 2023 Nov 7;:. - PMID 37931288

8

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

enthalten in: bioRxiv.org | 2023

von Middha, P. | Thummalapalli, R. | Betti, M. | +24

9

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Middha, P. | Thummalapalli, R. | Betti, M. | +25

UpdateIn: Nat Commun. 2024 Mar 26;15(1):2568. - PMID 38531883

10

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC : A Brief Report

enthalten in: JTO clinical and research reports | 2023

von Thummalapalli, R. | Choudhury, N. | Ehrich, F. | +10